Quality of life following surgery for intracranial meningiomas at Brigham and Women’s Hospital: A study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire

S. N. Kalkanis, Alfredo Quinones-Hinojosa, E. Buzney, H. J. Ribaudo, P. M.L. Black Mc L

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The objective of this study was to determine the subjectively reported quality of life (QOL) of patients with meningiomas surgically treated. Demographic, medical and outcomes data on 164 patients were retrospectively analyzed with the use of the Brain Tumor Center database at the Brigham and Women's Hospital, Boston, MA. The patients were contacted via a telephone survey and were asked 26 standardized QOL questions based on a modification of the validated Functional Assessment of Cancer Therapy-Brain (FACT-BR) Study, which used only questions adjuvant to brain tumor patients. The patients' ages ranged from 23 to 87 years. The mean follow-up time after intracranial surgery was 33 months and median follow-up time was 28 months, with a range of 0 to 165 months. Of those 164 patients still living, 95% (155) participated in the telephone survey. 80% reported being satisfied with their post-treatment quality of life; 86% reported that they could write, read, drive and return to work at their pre-morbid level of functioning; 87% described themselves as 'independent' and able to act on their own initiatives. Our study found a high level of satisfaction for QOL in patients who have undergone surgery for intracranial meningiomas. Patients, by their own report, are able to lead independent, personally satisfying, meaningful and productive lives. This provides useful information to share with patients in discussions regarding surgical treatment of these lesions.

Original languageEnglish (US)
Article number270019
Pages (from-to)233-241
Number of pages9
JournalJournal of Neuro-Oncology
Volume48
Issue number3
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Meningioma
Brain Neoplasms
Quality of Life
Therapeutics
Telephone
Surveys and Questionnaires
Return to Work
Demography
Databases

Keywords

  • Intracranial surgery
  • Meningioma
  • Quality of life
  • Treatment options-meningioma surgery

ASJC Scopus subject areas

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

@article{4e7fffd60a4e48f2b9545bf97111d3aa,
title = "Quality of life following surgery for intracranial meningiomas at Brigham and Women’s Hospital: A study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire",
abstract = "The objective of this study was to determine the subjectively reported quality of life (QOL) of patients with meningiomas surgically treated. Demographic, medical and outcomes data on 164 patients were retrospectively analyzed with the use of the Brain Tumor Center database at the Brigham and Women's Hospital, Boston, MA. The patients were contacted via a telephone survey and were asked 26 standardized QOL questions based on a modification of the validated Functional Assessment of Cancer Therapy-Brain (FACT-BR) Study, which used only questions adjuvant to brain tumor patients. The patients' ages ranged from 23 to 87 years. The mean follow-up time after intracranial surgery was 33 months and median follow-up time was 28 months, with a range of 0 to 165 months. Of those 164 patients still living, 95{\%} (155) participated in the telephone survey. 80{\%} reported being satisfied with their post-treatment quality of life; 86{\%} reported that they could write, read, drive and return to work at their pre-morbid level of functioning; 87{\%} described themselves as 'independent' and able to act on their own initiatives. Our study found a high level of satisfaction for QOL in patients who have undergone surgery for intracranial meningiomas. Patients, by their own report, are able to lead independent, personally satisfying, meaningful and productive lives. This provides useful information to share with patients in discussions regarding surgical treatment of these lesions.",
keywords = "Intracranial surgery, Meningioma, Quality of life, Treatment options-meningioma surgery",
author = "Kalkanis, {S. N.} and Alfredo Quinones-Hinojosa and E. Buzney and Ribaudo, {H. J.} and {Black Mc L}, {P. M.L.}",
year = "2000",
doi = "10.1023/A:1006476604338",
language = "English (US)",
volume = "48",
pages = "233--241",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Quality of life following surgery for intracranial meningiomas at Brigham and Women’s Hospital

T2 - A study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire

AU - Kalkanis, S. N.

AU - Quinones-Hinojosa, Alfredo

AU - Buzney, E.

AU - Ribaudo, H. J.

AU - Black Mc L, P. M.L.

PY - 2000

Y1 - 2000

N2 - The objective of this study was to determine the subjectively reported quality of life (QOL) of patients with meningiomas surgically treated. Demographic, medical and outcomes data on 164 patients were retrospectively analyzed with the use of the Brain Tumor Center database at the Brigham and Women's Hospital, Boston, MA. The patients were contacted via a telephone survey and were asked 26 standardized QOL questions based on a modification of the validated Functional Assessment of Cancer Therapy-Brain (FACT-BR) Study, which used only questions adjuvant to brain tumor patients. The patients' ages ranged from 23 to 87 years. The mean follow-up time after intracranial surgery was 33 months and median follow-up time was 28 months, with a range of 0 to 165 months. Of those 164 patients still living, 95% (155) participated in the telephone survey. 80% reported being satisfied with their post-treatment quality of life; 86% reported that they could write, read, drive and return to work at their pre-morbid level of functioning; 87% described themselves as 'independent' and able to act on their own initiatives. Our study found a high level of satisfaction for QOL in patients who have undergone surgery for intracranial meningiomas. Patients, by their own report, are able to lead independent, personally satisfying, meaningful and productive lives. This provides useful information to share with patients in discussions regarding surgical treatment of these lesions.

AB - The objective of this study was to determine the subjectively reported quality of life (QOL) of patients with meningiomas surgically treated. Demographic, medical and outcomes data on 164 patients were retrospectively analyzed with the use of the Brain Tumor Center database at the Brigham and Women's Hospital, Boston, MA. The patients were contacted via a telephone survey and were asked 26 standardized QOL questions based on a modification of the validated Functional Assessment of Cancer Therapy-Brain (FACT-BR) Study, which used only questions adjuvant to brain tumor patients. The patients' ages ranged from 23 to 87 years. The mean follow-up time after intracranial surgery was 33 months and median follow-up time was 28 months, with a range of 0 to 165 months. Of those 164 patients still living, 95% (155) participated in the telephone survey. 80% reported being satisfied with their post-treatment quality of life; 86% reported that they could write, read, drive and return to work at their pre-morbid level of functioning; 87% described themselves as 'independent' and able to act on their own initiatives. Our study found a high level of satisfaction for QOL in patients who have undergone surgery for intracranial meningiomas. Patients, by their own report, are able to lead independent, personally satisfying, meaningful and productive lives. This provides useful information to share with patients in discussions regarding surgical treatment of these lesions.

KW - Intracranial surgery

KW - Meningioma

KW - Quality of life

KW - Treatment options-meningioma surgery

UR - http://www.scopus.com/inward/record.url?scp=0033767429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033767429&partnerID=8YFLogxK

U2 - 10.1023/A:1006476604338

DO - 10.1023/A:1006476604338

M3 - Article

C2 - 11100821

AN - SCOPUS:0033767429

VL - 48

SP - 233

EP - 241

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

M1 - 270019

ER -